Famed basketball coach tours nation to get word out on BPH
The Prostate Cancer Education Council, a nonprofit consortium of expert physicians, health educators, scientists, and prostate health advocates, is teaming with former Detroit Pistons basketball coach Chuck Daly to spread the word on prostate health issues. BPH Game Plan Starts with U, the culmination of their efforts, is a recently launched national initiative to promote screenings and to raise awareness of BPH.
The Prostate Cancer Education Council, a nonprofit consortium of expert physicians, health educators, scientists, and prostate health advocates, is teaming with former Detroit Pistons basketball coach Chuck Daly to spread the word on prostate health issues. BPH Game Plan Starts with U, the culmination of their efforts, is a recently launched national initiative to promote screenings and to raise awareness of BPH.
As part of the BPH Game Plan Starts with U initiative, Daly, who has had BPH for more than 20 years, will travel nationwide to recount his BPH experience and urge men to get evaluated.
"As a coach, I face problems head on. So when I was diagnosed with BPH, I made a game plan with my doctor," Daly said. "I hope that sharing my experiences can help other men to understand that BPH is a common condition and encourage them to work with their doctors to create a game plan of their own."
Your patients can visit www.talkaboutbph.com for more information on local screenings with Coach Daly and for a risk assessment tool.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
